The UK OFT issues a statement of objections to four pharmaceutical manufacturers for anticompetitive agreements over the supply of paroxetine (GSK / GUK / Alpharma / IVAX)

Accardo, Gabriele

Previous article The UK OFT issues statement of objections to four pharma companies alleging they acted to delay effective competition in the national supply of antidepressant medicine (GSK / GUK / Alpharma / IVAX) Next article The UK OFT issues statement of objections to certain pharmaceutical companies alleging they acted to delay effective competition in the UK supply of medicine (GSK / GUK / Alpharma / IVAX)

19 Apr 2013

The UK OFT issues a statement of objections to four pharmaceutical manufacturers for anticompetitive agreements over the supply of paroxetine (GSK / GUK / Alpharma / IVAX)

KEYWORDS

Reference

UK OFT, OFT issues statement of objections to certain pharmaceutical companies, Press release 36/13, 19 April 2013

UK OFT investigates GSK and generics manufacturers over pay for delay deals* On 19 April 2013 the UK Office of Fair Trading (“OFT”) issued a Statement of Objections to GlaxoSmithKline (“GSK”) and three generics manufacturers (Alpharma Limited, Generics UK Limited and Norton Healthcare Limited) alleging that they concluded

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

PDF Version

Author

Gabriele Accardo
Ashurst (Milan)

Italy 102 contributions 28467 visits

Quotation

Gabriele Accardo, The UK OFT issues a statement of objections to four pharmaceutical manufacturers for anticompetitive agreements over the supply of paroxetine (GSK / GUK / Alpharma / IVAX), 19 April 2013, e-Competitions Pay-for-delay agreements, Art. N° 57337

Visites 356